Riskpilot← Back to searchSign inGet full accessLEGE GJERPEN WOLD AS
ASActiveOrg 920218385Sandakerveien 20D, 0473 OsloGeneral medical practice activities · NACE 8621Est. 20181 employees
Revenue 2024
NOK 2,7M
+12% vs 2023
EBITDA margin
50.2%
+1% vs 2023
Equity ratio
57.7%
Financial strength
Net profit 2024
NOK 1,1M
+39% vs 2023
| Revenue | NOK 2,7M | +12% |
| EBITDA | NOK 1,3M | +1% |
| Net profit | NOK 1,1M | +39% |
| Total assets | NOK 1,1M | +24% |
| Equity | NOK 624K | +10% |
| Employees | 1 | — |
Legal name
LEGE GJERPEN WOLD AS
Org number
920218385
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
10. januar 2018
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmennmedisinsk behandling, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet og forvaltning av selskapets kapital og ressurser i form av investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning, kjøp, drift, oppføring og rehabilitering av fast eiendom.
Address
Sandakerveien 20D, 0473 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 181 | 2 601 | 2 242 | 2 376 | 2 663 |
| Staff expenses | −728 | −798 | −823 | −861 | −1 050 |
| EBITDA | 1 167 | 927 | 1 116 | 1 330 | 1 337 |
| Depreciation & amort. | −300 | −300 | −300 | −300 | −0 |
| EBIT | 867 | 627 | 816 | 1 030 | 1 337 |
| Net financials | −1 | −2 | −0 | −2 | −1 |
| Profit before tax | 867 | 625 | 816 | 1 029 | 1 336 |
| Tax | 204 | 161 | 212 | 265 | 272 |
| Net profit | 663 | 464 | 604 | 763 | 1 064 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 138 | 1 542 | 1 441 | 872 | 1 082 |
| Equity | 1 674 | 638 | 642 | 565 | 624 |
| Long-term debt | 155 | 585 | 394 | 4 | 5 |
| Short-term debt | 308 | 319 | 404 | 303 | 453 |
| Total debt | 464 | 904 | 799 | 307 | 458 |
EBITDA margin
50.2%
This company
15.8%
Market median
+218% vs market
20202024
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
170.5%
This company
18.4%
Market median
+827% vs market
20202024
Net profit margin
40.0%
This company
8.1%
Market median
+394% vs market
20202024
Asset turnover
2.46×
This company
1.12×
Market median
+120% vs market
20202024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LEGE GJERPEN WOLD AS 
KOLBOTN LEGESENTER ASBoard members of LEGE GJERPEN WOLD AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeanne Margrethe Gjerpen | Chief Executive Officer | 0 companies |
| Erlend Fornæss Wold | Board of Directors | 0 companies |